Hu Wen, Lin Xi, Qian Meng, Du Tao-Ming, Lan Xi
Department of Oncology, Chengdu Seventh People's Hospital, Chengdu 610000, Sichuan Province, China.
Department of Oncology, Yanting County People's Hospital, Mianyang 621600, Sichuan Province, China.
World J Gastrointest Oncol. 2023 Jul 15;15(7):1311-1316. doi: 10.4251/wjgo.v15.i7.1311.
Liver interventional surgery is a relatively safe and minimally invasive surgery. However, for patients who have undergone Whipple surgery, the probability of developing a liver abscess after liver interventional surgery is very high. Fungal liver abscess has a high mortality rate, especially when complicated with malignant tumors, diabetes, coronavirus disease 2019 (COVID-19) and other complications. Fungal liver abscess is rare, and there are no guidelines or expert consensus on the course of antifungal therapy.
A 54-year-old woman with pancreatic head cancer received albumin-bound paclitaxel in combination with gemcitabine chemotherapy after laparoscopic pancreaticoduodenectomy. Liver metastasis was found 1 mo after completion of 8 cycles of chemotherapy, followed by ablation of the liver metastasis. After half a month of liver metastasis ablation, the patient experienced fever after chemotherapy and was diagnosed with liver abscess complicated with COVID-19 by contrast-enhanced abdominal computed tomography and real-time polymerase chain reaction detection. The results of pus culture showed , which was sensitive to fluconazole. The patient underwent percutaneous catheter drainage, antifungal therapy with fluconazole, and antiviral therapy with azvudine. During antifungal therapy, the patient showed a significant increase in liver enzyme levels and was discharged after liver protection therapy. Oral fluconazole was continued for 1 wk outside the hospital, and fluconazole was used for a total of 5 wk. The patient recovered well and received 4 cycles of fluorouracil, leucovorin, oxaliplatin, and irinotecan after 2 mo of antifungal therapy.
Effective treatment of liver abscess requires early detection, percutaneous catheter drainage, and 5 wk of antifungal therapy. Meanwhile, complications such as COVID-19 should be actively managed and nutritional support should be provided.
肝脏介入手术是一种相对安全的微创手术。然而,对于接受过胰十二指肠切除术的患者,肝脏介入手术后发生肝脓肿的概率非常高。真菌性肝脓肿死亡率高,尤其是合并恶性肿瘤、糖尿病、2019冠状病毒病(COVID-19)等并发症时。真菌性肝脓肿较为罕见,关于抗真菌治疗疗程尚无指南或专家共识。
一名54岁的胰头癌女性患者在腹腔镜胰十二指肠切除术后接受了白蛋白结合型紫杉醇联合吉西他滨化疗。在完成8个周期化疗1个月后发现肝转移,随后对肝转移灶进行了消融。肝转移灶消融半个月后,患者化疗后出现发热,经腹部增强计算机断层扫描和实时聚合酶链反应检测诊断为肝脓肿合并COVID-19。脓液培养结果显示 ,对氟康唑敏感。患者接受了经皮导管引流、氟康唑抗真菌治疗和阿兹夫定抗病毒治疗。在抗真菌治疗期间,患者肝酶水平显著升高,经保肝治疗后出院。出院后继续口服氟康唑1周,氟康唑总共使用了5周。患者恢复良好,在抗真菌治疗2个月后接受了4个周期的氟尿嘧啶、亚叶酸钙、奥沙利铂和伊立替康治疗。
有效治疗肝脓肿需要早期发现、经皮导管引流以及5周的抗真菌治疗。同时,应积极处理COVID-19等并发症并提供营养支持。